Cite

HARVARD Citation

    Gallitto, M. et al. (2019). Trimodality therapy for oropharyngeal cancer in the TORS era: Is there a cohort that may benefit?. Head & neck. 41 (9), pp. 3009-3022. [Online]. 
  
Back to record